The following medical description of a pancreas is provided. This is a medical observation from a doctor. The doctor notes one or multiple cysts and their dimensions. From the potentially multiple size values, the doctor is looking for the largest dimension of any of the cyst observations which is called the dominant cyst size. 

    ***Examples: 
    Pancreas: 'There is again noted to be markedly atrophic with fatty replacement, similar to prior study. There is possibly a cystic lesion in the tail the pancreas that measures up to 2.2 cm and possibly, a second adjacent cystic lesion that measures approximately 1.4 cm. These appear similar to prior study. They possibly represent pseudocysts although other cystic lesions of the pancreas do not be excluded. It is also conceivable be simply represent fluid filled small bowel loops although it would be somewhat unusual for them to have the same appearance over multiple studies. 
    Dominant Cyst Size: 2.2 cm

    Pancreas: 'Numerous pancreatic cystic lesions are redemonstrated measuring up to 2.1 cm. These are nonspecific and may represent sequela of prior pancreatitis or sidebranch IPMNs. These can be reassessed with MRI in one year.'
    Dominant Cyst Size: 2.1cm

    Pancreas: 'Pancreas: Pancreas appear atrophic. Hypodense lesion seen in the uncinate process of the pancreas (series 6 images 519) measuring 1.6 x 2.3 cm previously measuring 2.4 x 1.0 cm. Another well-defined cystic attenuation lesion seen in the body of the pancreas extending inferiorly measuring 1.6 x 2.1 cm and tail of the pancreas measuring 1.2 x 1.6 cm not well appreciated on prior scan due to movement artifact measuring approximately 1.5 cm on 9/7/2021.'

    Dominant Cyst Size: 2.4 cm

    Pancreas: 'Pancreas: A 3 cm x 2.7 cm pancreatic tail cystic lesion has increased in size from prior (previously 2.4 cm x 1.9 cm). An approximately 1 cm pancreatic neck cyst, now measures about 3.1 cm cyst associated centimeters previously along the maximum transverse dimension. Remainder of the pancreas is unchanged.'
    Dominant Cyst Size: 3.1 cm

    Pancreas: 'PANCREAS: Evaluation of the pancreatic cystic lesions is limited by CT technique. Although the largest lesion in the body of the pancreas is stable, measuring up to 14 mm. No pancreatic ductal dilatation. No findings of acute pancreatitis.'
    Dominant Cyst Size : 14 mm
    
    ***Input
    Pancreas:  
FINDINGS:
 
A few scattered simple appearing pancreatic cystic lesions without internal solid enhancing components are stable. The largest of these measures 2.3 cm in the region of the pancreatic neck. No pancreatic ductal dilatation is identified. Findings remain nonspecific and could reflect sidebranch intraductal papillary mucinous neoplasms and/or the sequela of prior pancreatitis. No solid enhancing pancreatic masses are identified.
 
The spleen and adrenal glands are unremarkable. Cholelithiasis is again noted. There is no biliary ductal dilatation. A few scattered liver cysts are not significantly changed. A few renal cysts are also unchanged with a right renal cyst again noted to contain hemorrhagic/proteinaceous debris. There is a stable polypoid lesion associated with the duodenum (image 21, series 4. There is no abdominal adenopathy or ascites.
 MRI ABDOMEN W WO IV CONTRAST
 
Clinical history: Pancreatic cyst/pseudo cyst, follow up. Additional history of lymphoma.
 
Comparison: MRI dated February 22, 2019. A more recent CT study from January 15, 2020 is available for review, however the pancreatic lesions are better seen on the prior MRI.
 
TECHNIQUE: Multiplanar, multi sequential MR imaging was performed with and without intravenous contrast. 18 cc of intravenous Dotarem was given.
 
FINDINGS:
 
A few scattered simple appearing pancreatic cystic lesions without internal solid enhancing components are stable. The largest of these measures 2.3 cm in the region of the pancreatic neck. No pancreatic ductal dilatation is identified. Findings remain nonspecific and could reflect sidebranch intraductal papillary mucinous neoplasms and/or the sequela of prior pancreatitis. No solid enhancing pancreatic masses are identified.
 
The spleen and adrenal glands are unremarkable. Cholelithiasis is again noted. There is no biliary ductal dilatation. A few scattered liver cysts are not significantly changed. A few renal cysts are also unchanged with a right renal cyst again noted to contain hemorrhagic/proteinaceous debris. There is a stable polypoid lesion associated with the duodenum (image 21, series 4. There is no abdominal adenopathy or ascites.
 MRI ABDOMEN W WO IV CONTRAST
 
Clinical history: Pancreatic cyst/pseudo cyst, follow up. Additional history of lymphoma.
 
Comparison: MRI dated February 22, 2019. A more recent CT study from January 15, 2020 is available for review, however the pancreatic lesions are better seen on the prior MRI.
 
TECHNIQUE: Multiplanar, multi sequential MR imaging was performed with and without intravenous contrast. 18 cc of intravenous Dotarem was given.
 
FINDINGS:
 
A few scattered simple appearing pancreatic cystic lesions without internal solid enhancing components are stable. The largest of these measures 2.3 cm in the region of the pancreatic neck. No pancreatic ductal dilatation is identified. Findings remain nonspecific and could reflect sidebranch intraductal papillary mucinous neoplasms and/or the sequela of prior pancreatitis. No solid enhancing pancreatic masses are identified.
 
The spleen and adrenal glands are unremarkable. Cholelithiasis is again noted. There is no biliary ductal dilatation. A few scattered liver cysts are not significantly changed. A few renal cysts are also unchanged with a right renal cyst again noted to contain hemorrhagic/proteinaceous debris. There is a stable polypoid lesion associated with the duodenum (image 21, series 4. There is no abdominal adenopathy or ascites.
 Conclusion

MRI ABDOMEN W WO IV CONTRAST
 
Clinical history: Pancreatic cyst/pseudo cyst, follow up. Additional history of lymphoma.
 
Comparison: MRI dated February 22, 2019. A more recent CT study from January 15, 2020 is available for review, however the pancreatic lesions are better seen on the prior MRI.
 
TECHNIQUE: Multiplanar, multi sequential MR imaging was performed with and without intravenous contrast. 18 cc of intravenous Dotarem was given.
 
FINDINGS:
 
A few scattered simple appearing pancreatic cystic lesions without internal solid enhancing components are stable. The largest of these measures 2.3 cm in the region of the pancreatic neck. No pancreatic ductal dilatation is identified. Findings remain nonspecific and could reflect sidebranch intraductal papillary mucinous neoplasms and/or the sequela of prior pancreatitis. No solid enhancing pancreatic masses are identified.
 
The spleen and adrenal glands are unremarkable. Cholelithiasis is again noted. There is no biliary ductal dilatation. A few scattered liver cysts are not significantly changed. A few renal cysts are also unchanged with a right renal cyst again noted to contain hemorrhagic/proteinaceous debris. There is a stable polypoid lesion associated with the duodenum (image 21, series 4. There is no abdominal adenopathy or ascites.
 
    Output: 
    